ATE29837T1 - Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff. - Google Patents

Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff.

Info

Publication number
ATE29837T1
ATE29837T1 AT81101642T AT81101642T ATE29837T1 AT E29837 T1 ATE29837 T1 AT E29837T1 AT 81101642 T AT81101642 T AT 81101642T AT 81101642 T AT81101642 T AT 81101642T AT E29837 T1 ATE29837 T1 AT E29837T1
Authority
AT
Austria
Prior art keywords
beta
excipients
lactam antibiotic
oral use
use containing
Prior art date
Application number
AT81101642T
Other languages
English (en)
Inventor
Takeru Higuchi
Toshiaki Nishihata
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Application granted granted Critical
Publication of ATE29837T1 publication Critical patent/ATE29837T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT81101642T 1980-03-07 1981-03-06 Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff. ATE29837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12809980A 1980-03-07 1980-03-07
EP81101642A EP0036534B1 (de) 1980-03-07 1981-03-06 Arzneimittelformulierung zur oralen Verabreichung mit Gehalt an einem beta-Lactam-Antibiotikum und einem Hilfsstoff

Publications (1)

Publication Number Publication Date
ATE29837T1 true ATE29837T1 (de) 1987-10-15

Family

ID=22433628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81101642T ATE29837T1 (de) 1980-03-07 1981-03-06 Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff.

Country Status (11)

Country Link
EP (1) EP0036534B1 (de)
JP (1) JPS56128714A (de)
AT (1) ATE29837T1 (de)
DE (1) DE3176461D1 (de)
DK (1) DK101981A (de)
ES (1) ES8301107A1 (de)
FI (1) FI810637L (de)
GR (1) GR74441B (de)
IE (1) IE52973B1 (de)
NO (1) NO159767C (de)
PT (1) PT72616B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH05248655A (ja) * 1992-01-09 1993-09-24 Daikin Ind Ltd 空気調和装置
ATE171616T1 (de) * 1992-05-15 1998-10-15 Shiseido Co Ltd Äusserliches hautpräparat
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
CA2275475A1 (en) * 1996-12-19 1998-06-25 Hiroshi Kikuchi Pharmaceutical composition for oral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1036194A (en) * 1962-03-26 1966-07-13 William Kurt Wallersteiner Improvements relating to antibiotic compositions
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
NO810758L (no) 1981-09-08
ES500184A0 (es) 1982-12-01
NO159767B (no) 1988-10-31
GR74441B (de) 1984-06-28
EP0036534A1 (de) 1981-09-30
ES8301107A1 (es) 1982-12-01
IE810452L (en) 1981-09-07
JPS6346727B2 (de) 1988-09-19
NO159767C (no) 1989-02-08
FI810637L (fi) 1981-09-08
PT72616A (en) 1981-04-01
EP0036534B1 (de) 1987-09-23
DE3176461D1 (en) 1987-10-29
IE52973B1 (en) 1988-04-27
DK101981A (da) 1981-09-08
JPS56128714A (en) 1981-10-08
PT72616B (en) 1985-10-04

Similar Documents

Publication Publication Date Title
ATE13487T1 (de) Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff.
HUT50779A (en) Process for producing alpha-substituted 4-/quinolin-2-yl-methoxy/-phenyl-acetic acids and esters and pharmaceutical compositions containing them
ATE29837T1 (de) Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem beta-lactam-antibiotikum und einem hilfsstoff.
ES8106528A1 (es) Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam
ATE24398T1 (de) Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem glycosid antibiotikum und einem hilfsstoff.
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
FI884911A0 (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
SE8005309L (sv) Nya 5alfa-pregnan-20-ol-derivat och salter derav med syror, sett for framstellning samt anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
PL245813A1 (en) Process for preparing 6-alpha-methoxy-6-beta(2-/methylphenoxycarbonyl/-2-/thienyl-3/-acetamido)-penicillanic acid
IT1246285B (it) Composizione farmaceutica per il trattamento delle infezioni polmonari

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee